OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update GlobeNewswire November 06, 2025 — First patients dosed in triplet expansion arms of the PIKture-01 trial evaluating OKI-219 in combination with fulvestrant and ribociclib, and in combination with trastuzumab and tucatinib in patients with metastatic breast cancer — Clinical data from OKI-219 […]
— The Company expects to file a protocol amendment in the INVINCIBLE-4 Study to revise the dosing regimen for the INT230-6 treatment cohort, and to reinitiate patient enrollment in the first quarter of 2026 — IT-01 Study manuscript published, featuring a comprehensive evaluation of data, including disease control rate, overall survival, immune activation, abscopal effects,
First Emergency Response grant will reach 34,483 students through local consortium led by the Rural Support Programmes Network Education Cannot Wait (ECW) announced today a US$2 million First Emergency Response grant to address the urgent education needs of children affected by Pakistan's devastating monsoon floods. https://mma.prnewswire.com/media/2816226/Education_Cannot_Wait.jpg The 12-month grant will be delivered by the Rural
(NasdaqGM:GPCR), Topline 36-week data from oral small molecule GLP-1 receptor agonist aleniglipron ACCESS and ACCESS II studies on track for readouts by year-end 2025 Oral small molecule amylin receptor agonist (ACCG-2671) Phase 1 study initiation anticipated by year-end 2025; second oral amylin receptor agonist (ACCG-3535) development candidate declared Strong financial position with cash, cash equivalents
(NASDAQ:BLNK), Revenue Growth, Operational Discipline, and Strategic Focus Position Blink for Solid Q4 Bowie, MD., Nov. 06, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced financial results for the third quarter ended September
(NASDAQ:DMLP), DALLAS, Nov. 06, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announced today the Partnership's net income for the quarter ended September 30, 2025 of $11,173,000, or $0.23 per common unit. A comparison of the Partnership's consolidated results for the quarters ended September 30, 2025 and 2024 are set forth below: Three
(NASDAQ:VTYX), Data from the recent Phase 2 study position Ventyx's NLRP3 inhibitor VTX3232 as a next generation, oral anti-inflammatory therapy, for cardiovascular disease Positive topline data from Phase 2a biomarker trial support the potential use of VTX3232 as a disease-modifying therapy for patients with Parkinson's disease Topline data from Phase 2 study of VTX2735 in
(NASDAQ:WSC), SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) — WillScot Holdings Corporation (“WillScot” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary space solutions, today announced that its Board of Directors has declared a quarterly dividend of $0.07 per common share. The cash dividend will be paid on December 17, 2025, to shareholders of
(NASDAQ:CMND),(Frankfurt:CWY0), The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected by receipt of the Notification Letter Vancouver, Canada, Nov. 06, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech
(NASDAQ:RUN),(NYSE:CWEN),(NYSE:CWEN.A),(NYSE:CWEN-A), SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today announced the appointment of Craig Cornelius as a member of Sunrun's board of directors (the “Board”). Mr. Cornelius brings two decades of industry experience across the renewable energy space. “I